Dentium CO., LTD (KRX:145720)
South Korea · Delayed Price · Currency is KRW 56,400
+900 (1.62%)
At close: Oct 2, 2025
Dentium CO., LTD Market Cap
Dentium CO., LTD has a market cap or net worth of 486.39 billion as of October 6, 2025. Its market cap has decreased by -22.95% in one year.
Market Cap
486.39B
Enterprise Value
656.57B
Revenue
372.49B
Ranking
n/a
PE Ratio
9.22
Stock Price
56,400.00
Market Cap Chart
Since March 15, 2017, Dentium CO., LTD's market cap has increased from 295.94B to 486.39B, an increase of 64.35%. That is a compound annual growth rate of 5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 486.39B | -9.32% |
| Dec 30, 2024 | 536.41B | -52.52% |
| Dec 28, 2023 | 1,129.73B | 31.00% |
| Dec 29, 2022 | 862.39B | 43.27% |
| Dec 30, 2021 | 601.95B | 69.83% |
| Dec 30, 2020 | 354.44B | -23.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |